Summary:
Multicenter, double-blind, randomized, placebo-controlled,
parallel‑group, proof-of-concept study to evaluate the efficacy
and safety of oral ACT-539313 in the treatment of adults with
moderate to severe binge eating disorder.
Qualified Participants Must:
• Male or female aged 18 to 55 years
•
Have self-reported binge eating episodes (4-7 a week)
•
Be willing to refrain from medical marijuana use, nicotine, or other illicit substances during the duration of the study
*Other qualifications apply, please contact our office for more
Qualified Participants May Receive:
Compensation for time and travel upon qualifications.